Wyeth Again Defends Pristiq

Wyeth(WYE Quote) is reaffirming its belief that Pristiq, its experimental drug for menopause symptoms, is safe and effective.

The company also said it thinks the Food and Drug Administration's request last week for another clinical trial won't affect the agency's review of Pristiq as a treatment for depression.

Greg Norden, Wyeth's chief financial officer, said Tuesday that he expects the agency to rule favorably on the depression application during the first quarter of 2008. The depression application is being reviewed by a different unit in the FDA than the menopause application. ...